Evogene Ltd. (TLV:EVGN)
256.90
+7.00 (2.80%)
Apr 3, 2026, 1:44 PM IDT
Evogene Revenue
In the year 2025, Evogene had annual revenue of $3.85M USD, down -30.91%. Evogene had revenue of $314.00K in the quarter ending December 31, 2025.
Revenue
$3.85M
Revenue Growth
-30.91%
P/S Ratio
2.07
Revenue / Employee
$32.93K
Employees
117
Market Cap
25.42M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.85M | -1.72M | -30.91% |
| Dec 31, 2024 | 5.58M | 2.60M | 87.02% |
| Dec 31, 2023 | 2.98M | 1.31M | 78.03% |
| Dec 31, 2022 | 1.68M | 745.00K | 80.11% |
| Dec 31, 2021 | 930.00K | -110.00K | -10.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Clal Biotechnology Industries | 11.55M |
| BioLineRx | 3.76M |
| XTL Biopharmaceuticals | 3.26M |
| Can-Fite BioPharma | 1.29M |
| Geffen Residence & Renewal | 78.00K |
| BioLight Life Sciences | 21.00K |
Evogene News
- 1 day ago - Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification - PRNewsWire
- 4 days ago - Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock - PRNewsWire
- 21 days ago - Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline - GuruFocus
- 21 days ago - Q4 2025 Evogene Ltd Earnings Call Transcript - GuruFocus
- 26 days ago - Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 - PRNewsWire
- 4 weeks ago - Evogene (EVGN) Focuses on Key Markets Following Strategic Shift - GuruFocus
- 4 weeks ago - Evogene Earnings Review: Q4 Summary - Benzinga
- 4 weeks ago - Evogene Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire